Lankide:Bcpgials/Proba orria2
Appearance
subset[aldatu | aldatu iturburu kodea]
Title | Page ID | Namespace | Size (bytes) | Last change |
---|---|---|---|---|
[[Blood–brain barrier|]] | 84936 | 0 | 54393 | 20190117105105 |
[[Intravenous therapy|]] | 178769 | 0 | 40184 | 20190108160032 |
[[Route of administration|]] | 334816 | 0 | 29025 | 20190115070859 |
[[Subcutaneous injection|]] | 334820 | 0 | 4046 | 20190107095300 |
[[Intramuscular injection|]] | 334821 | 0 | 8579 | 20190107095300 |
[[Therapeutic index|]] | 334955 | 0 | 20399 | 20181231145536 |
[[Injection (medicine)|]] | 665909 | 0 | 14929 | 20190111154901 |
[[Cytochrome P450|]] | 709137 | 0 | 49994 | 20190117100127 |
[[Therapeutic drug monitoring|]] | 739219 | 0 | 4914 | 20181217063807 |
[[Bioavailability|]] | 769021 | 0 | 22147 | 20181204133035 |
[[ADME|]] | 826690 | 0 | 6152 | 20181208191145 |
[[Bioequivalence|]] | 998103 | 0 | 14201 | 20181202155139 |
[[Prodrug|]] | 1017427 | 0 | 12119 | 20190105155457 |
[[Cimetidine|]] | 1018112 | 0 | 50117 | 20190107221409 |
[[CYP3A4|]] | 1024582 | 0 | 48387 | 20190117100132 |
[[CYP2D6|]] | 1024815 | 0 | 29535 | 20190117100132 |
[[CYP2E1|]] | 1024830 | 0 | 23203 | 20190117100132 |
[[Polypharmacy|]] | 1099391 | 0 | 25926 | 20190103145504 |
[[Drug interaction|]] | 1099396 | 0 | 44028 | 20190115190456 |
[[Toxicokinetics|]] | 1112289 | 0 | 3616 | 20181124175936 |
[[Drug metabolism|]] | 1173475 | 0 | 28070 | 20190117062839 |
[[Toxication|]] | 1173482 | 0 | 8800 | 20181117220121 |
[[First pass effect|]] | 1173539 | 0 | 4796 | 20181231150249 |
[[Volume of distribution|]] | 1272743 | 0 | 7013 | 20181109232927 |
[[Aromatase|]] | 1415048 | 0 | 27049 | 20190117100137 |
[[Physiologically based pharmacokinetic modelling|]] | 1566437 | 0 | 25277 | 20181117220123 |
[[Effective half-life|]] | 1728145 | 0 | 2594 | 20181010124401 |
[[Drug action|]] | 2070741 | 0 | 5915 | 20181221103905 |
[[Polymersome|]] | 2218269 | 0 | 6943 | 20180929133937 |
[[Clearance (pharmacology)|]] | 2402393 | 0 | 13244 | 20190114112233 |
[[Haber's rule|]] | 2463278 | 0 | 3182 | 20181004165113 |
[[CYP2A6|]] | 2516515 | 0 | 11644 | 20190117100155 |
[[Enteric coating|]] | 2910903 | 0 | 9850 | 20190113221504 |
[[Trough level|]] | 2962530 | 0 | 1936 | 20181010124518 |
[[Biological half-life|]] | 3206099 | 0 | 13872 | 20181117220129 |
[[Loading dose|]] | 3291372 | 0 | 3766 | 20181109232927 |
[[Distribution (pharmacology)|]] | 3665681 | 0 | 9706 | 20181127032709 |
[[Microdosing|]] | 3845621 | 0 | 5774 | 20190114190444 |
[[Ethnopsychopharmacology|]] | 4189719 | 0 | 7015 | 20181014221721 |
[[P450-containing systems|]] | 4277840 | 0 | 10609 | 20190117100221 |
[[CYP1A2|]] | 4320289 | 0 | 22911 | 20190117100221 |
[[Epoxyeicosatrienoic acid|]] | 4367754 | 0 | 49168 | 20190115133053 |
[[Grapefruit–drug interactions|]] | 4387617 | 0 | 55511 | 20181231234649 |
[[Initial volume of distribution|]] | 4629153 | 0 | 1687 | 20181221105004 |
[[CYP2C9|]] | 4779665 | 0 | 27521 | 20190117100228 |
[[CYP2C19|]] | 4779761 | 0 | 23851 | 20190117100228 |
[[CYP2C8|]] | 4779795 | 0 | 13153 | 20190117100228 |
[[Cytochrome P450, family 1, member A1|]] | 5119921 | 0 | 14296 | 20190117100234 |
[[Enzyme induction and inhibition|]] | 5245810 | 0 | 2570 | 20180929134736 |
[[Context-sensitive half-life|]] | 5507641 | 0 | 5320 | 20181222034944 |
[[CYP1B1|]] | 5900320 | 0 | 8431 | 20190117100250 |
[[CYP17A1|]] | 5914077 | 0 | 19201 | 20190117100250 |
[[Plasma protein binding|]] | 6025636 | 0 | 8443 | 20190114190623 |
[[Binding potential|]] | 6075099 | 0 | 5734 | 20180929134930 |
[[Absorption (pharmacology)|]] | 6194872 | 0 | 8109 | 20181227105718 |
[[Targeted drug delivery|]] | 6470547 | 0 | 29101 | 20181117220136 |
[[CYP27A1|]] | 6700732 | 0 | 10770 | 20190117100419 |
[[Cholesterol side-chain cleavage enzyme|]] | 6796314 | 0 | 22369 | 20190117100422 |
[[Dosage form|]] | 7481381 | 0 | 5887 | 20190112170427 |
[[Osmotic-controlled release oral delivery system|]] | 8031252 | 0 | 12541 | 20190107095300 |
[[21-Hydroxylase|]] | 8852888 | 0 | 17070 | 20190117100519 |
[[Modified-release dosage|]] | 9360334 | 0 | 24525 | 20190115023910 |
[[NONMEM|]] | 9365585 | 0 | 2303 | 20181023170705 |
[[Pharmacokinetics|]] | 9674107 | 0 | 39961 | 20190111155232 |
[[Cytochrome P450 reductase|]] | 9736045 | 0 | 18592 | 20190117100553 |
[[Pharmacometrics|]] | 10162690 | 0 | 5168 | 20190108081442 |
[[Dose (biochemistry)|]] | 10449471 | 0 | 19391 | 20181117220144 |
[[CYP2B6|]] | 10456228 | 0 | 15614 | 20190117100638 |
[[CYP3A7|]] | 10680502 | 0 | 2223 | 20190117100650 |
[[Lanosterol 14 alpha-demethylase|]] | 10906045 | 0 | 15122 | 20190117100705 |
[[PEGylation|]] | 10931846 | 0 | 17579 | 20181125212916 |
[[Bolus (medicine)|]] | 12238660 | 0 | 4028 | 20190107095300 |
[[Dissolution testing|]] | 12458572 | 0 | 9824 | 20180727142641 |
[[Flip-flop kinetics|]] | 13589014 | 0 | 1806 | 20170925222345 |
[[Dose dumping|]] | 14007566 | 0 | 1873 | 20190105155735 |
[[Cholesterol 24-hydroxylase|]] | 14045189 | 0 | 18819 | 20190117100815 |
[[IdMOC|]] | 14350461 | 0 | 3830 | 20190116030740 |
[[Ion trapping|]] | 14440094 | 0 | 4782 | 20181030184709 |
[[Active metabolite|]] | 14564960 | 0 | 3539 | 20190116030743 |
[[CYP3A|]] | 14798557 | 0 | 8481 | 20190117100835 |
[[Table of volume of distribution for drugs|]] | 14848284 | 0 | 1952 | 20180929140604 |
[[Compartment (pharmacokinetics)|]] | 14848805 | 0 | 1715 | 20181109232927 |
[[Table of medication secernated in kidney|]] | 14848938 | 0 | 4653 | 20181026163436 |
[[Skin popping|]] | 15151817 | 0 | 2523 | 20190107135449 |
[[Magnetic marker monitoring|]] | 15342613 | 0 | 2193 | 20181010125624 |
[[Simcyp Simulator|]] | 16157480 | 0 | 3740 | 20180929140750 |
[[Maintenance dose|]] | 16698745 | 0 | 2530 | 20181109232927 |
[[Free fraction|]] | 16823207 | 0 | 3223 | 20181221113956 |
[[CYP2C9*13|]] | 18420839 | 0 | 7711 | 20190117101022 |
[[Rate of infusion|]] | 18872320 | 0 | 1105 | 20181109232927 |
[[Elimination rate constant|]] | 19094964 | 0 | 3366 | 20181109232927 |
[[Dermal patch|]] | 20016657 | 0 | 1211 | 20190116030827 |
[[CYP2C9*3|]] | 22685256 | 0 | 1478 | 20190117101216 |
[[Chemotactic drug-targeting|]] | 22787622 | 0 | 1696 | 20181221115703 |
[[Cmin|]] | 22982241 | 0 | 1264 | 20181222035059 |
[[Cmax (pharmacology)|]] | 23184916 | 0 | 3490 | 20190114174555 |
[[Area under the curve (pharmacokinetics)|]] | 23518221 | 0 | 3802 | 20181109005510 |
[[Bioanalysis|]] | 23604382 | 0 | 6026 | 20180929142056 |
[[Dihydromethysticin|]] | 24225451 | 0 | 4389 | 20181223230630 |
[[Plateau principle|]] | 24608545 | 0 | 22889 | 20180522075742 |
[[Epsilon-Viniferin|]] | 24650277 | 0 | 7034 | 20181215042312 |
[[Onset of action|]] | 24697544 | 0 | 1906 | 20181222035104 |
[[Intradermal injection|]] | 25284347 | 0 | 3397 | 20181024105058 |
[[Proadifen|]] | 25296374 | 0 | 3252 | 20181214171239 |
[[Amentoflavone|]] | 26370272 | 0 | 6224 | 20190110031351 |
[[PK/PD models|]] | 26390451 | 0 | 5349 | 20181124062011 |
[[Oculomucocutaneous syndrome|]] | 28104937 | 0 | 1640 | 20190106161817 |
[[Lipophilic efficiency|]] | 28819446 | 0 | 5742 | 20181119052101 |
[[Parallel artificial membrane permeability assay|]] | 28893371 | 0 | 5083 | 20181117220204 |
[[Cobicistat|]] | 29240014 | 0 | 10662 | 20190111100418 |
[[Cooperstown cocktail|]] | 31190054 | 0 | 2748 | 20181221121832 |
[[PottersWheel|]] | 31376465 | 0 | 8275 | 20190115122951 |
[[Rhapontigenin|]] | 35281330 | 0 | 3510 | 20181214171240 |
[[Blood–gas partition coefficient|]] | 35737600 | 0 | 4185 | 20181205223518 |
[[Liberation (pharmacology)|]] | 39490884 | 0 | 4011 | 20181222035144 |
[[Elimination (pharmacology)|]] | 39490943 | 0 | 7081 | 20190116031029 |
[[20-Hydroxyeicosatetraenoic acid|]] | 47836404 | 0 | 79670 | 20190115133053 |
[[Epoxydocosapentaenoic acid|]] | 49599350 | 0 | 15811 | 20181016222046 |
[[Epoxyeicosatetraenoic acid|]] | 49854427 | 0 | 23013 | 20180929145841 |
[[Cytochrome P450 omega hydroxylase|]] | 50110441 | 0 | 12100 | 20180929145902 |
[[Residence time|]] | 50390340 | 0 | 32156 | 20190110022349 |
[[Variable volume pharmacokinetic models|]] | 51553756 | 0 | 4901 | 20180929150119 |
[[Intracerebroventricular injection|]] | 53597220 | 0 | 2784 | 20181117220233 |
[[Physical pharmacy|]] | 57989671 | 0 | 2480 | 20190108191157 |
[[Drug accumulation ratio|]] | 57998655 | 0 | 315 | 20181010132647 |
[[Cmean (pharmacology)|]] | 58105226 | 0 | 584 | 20181010132652 |